Boston's EB-1A ecosystem

Why Boston generates EB-1A petitions.

EB-1A is a self-petitioned immigrant visa — no employer, no job offer, no PERM labor certification. The evidentiary standard is the same extraordinary ability standard as O-1A, but the outcome is a permanent green card rather than a temporary work visa. For Boston researchers, this distinction matters enormously: if your record is strong enough, you can pursue permanence entirely on your own terms.

Boston researchers are uniquely positioned for EB-1A. The city's dense citation networks, institutional name recognition, and decades of peer-review history mean that the kind of record USCIS looks for — papers cited by others, panels judged, prizes from recognized organizations, critical roles in distinguished institutions — is simply part of the daily work product at MIT, Harvard, the Broad Institute, and the Kendall Square corridor.

Unlike many cities, Boston's major research institutions actively support EB-1A and EB-1B filings from the same evidence package. Lab directors regularly write expert opinion letters for colleagues. Institutional immigration offices know what USCIS expects. And because so many researchers in this geography are filing at the same time, there are tested petition strategies that map well to the Boston research profile specifically.

Many Boston researchers file O-1A and EB-1A simultaneously using a shared evidence package. O-1A provides immediate nonimmigrant work authorization while the EB-1A I-140 moves through adjudication. This dual-track approach — one petition for today, one for permanence — is one of the most efficient immigration strategies available in the Boston market.

Key institutions

Where Boston EB-1A petitions originate.

These institutions produce the largest share of Boston-area EB-1A petitions. Each has distinct research profiles and sponsorship practices that shape the I-140 self-petition strategy.

MIT & Harvard University
Both institutions generate high-volume EB-1A I-140 filings. Researchers here often file self-petitioned EB-1A concurrently with an employer-sponsored EB-1B, running two parallel green card paths with no PERM on either.
Broad Institute of MIT & Harvard
Staff scientists at the Broad typically have the publication, citation, and patent records for a strong EB-1A self-petition. The Broad's institutional affiliation itself serves as evidence of a distinguished organization.
Dana-Farber / Mass General / BWH
Harvard-affiliated teaching hospitals with deep oncology, immunology, and clinical research output. Instructor and research scientist tracks here generate strong EB-1A profiles. Concurrent O-1A+EB-1A filing is routine.
Kendall Square biotech corridor
Industry scientists at Biogen, Moderna, Vertex, Sanofi, and Novartis often have salary, patent, and press-coverage evidence that directly satisfies EB-1A criteria. Many self-petition EB-1A while their employer sponsors a separate EB-1B.
Whitehead Institute & Koch Institute
MIT-affiliated research institutes with strong citation records and institutional prestige. Independent research fellows often file EB-1A through an attorney acting as their representative, with no employer involvement required.
Harvard Chan School & Northeastern
Public health and engineering researchers here frequently meet EB-1A criteria through NIH/NSF-funded work, peer review activity, and invited talks. Many also qualify for EB-2 NIW and consider both paths simultaneously.
Eligibility

Which EB-1A criteria apply to Boston researchers.

EB-1A requires at least three of ten regulatory criteria, followed by a final merits assessment. For Boston researchers and scientists, these five come up most often:

01

Scholarly articles in peer-reviewed journals

A strong publication record in journals such as Nature, Science, Cell, NEJM, PNAS, or Nature Methods typically satisfies this criterion. First-authorship and corresponding-authorship carry particular weight. This is the baseline for almost every Boston academic profile and the most commonly met criterion in EB-1A petitions from this geography.

02

Original contributions of major significance

NIH-funded discoveries, first-author papers cited heavily by other researchers, methodological breakthroughs, platform technologies, or clinical findings that changed how peers approach a problem. USCIS looks for evidence that your work has been adopted by the field: citation analysis, expert letters explaining downstream impact, and references in subsequent publications citing your methodology.

03

Critical or leading role in a distinguished organization

Principal investigator, lab director, staff scientist leading a program, or principal/senior scientist owning a therapeutic pipeline at a named biotech. USCIS evaluates whether the role is indispensable to an institution recognized as distinguished. MIT labs, Harvard-affiliated hospitals, and Kendall Square companies with global recognition typically clear this bar with thorough documentation.

04

Judging the work of others

Ad hoc reviewing for high-impact journals, NIH study section membership, NSF or DOD grant panel participation, conference abstract review, or editorial board service. Most Boston researchers are doing significantly more peer reviewing than they realize. This criterion is documented with invitation letters and confirmation emails from journal editors or grant agencies.

05

High salary or remuneration relative to peers

Biotech compensation at the principal scientist, associate director, and above levels in the Kendall Square corridor frequently places candidates in the top 10–20% of their field nationally. This criterion is strongest for industry scientists but also applies to named professorships, endowed chairs, and certain NIH K-award recipients whose total compensation packages are demonstrably above field median.

Boston EB-1A profiles

What qualifying records look like here.

Representative profiles from Boston-area EB-1A I-140 petitions. Identifying details have been generalized.

Senior Postdoc / Research Scientist
Harvard Medical School

Tumor immunology, K99 awardee

44 peer-reviewed publications; 4 first-author papers in Cancer Cell and Immunity
NIH K99 career development award; co-investigator on active R01
Ad hoc reviewer for JCI, Cancer Research, and Nature Immunology
Invited speaker at AACR Annual Meeting and Gordon Research Conference
Findings cited in two published clinical trial protocols
Self-petitioned EB-1A I-140 filed concurrently with O-1A renewal. Institution provided critical-role letter and expert opinion confirming field impact.
Staff Scientist
Broad Institute of MIT & Harvard

Computational genomics, tools and methods

58 publications; 3 first-author papers in Nature Methods and Genome Research
h-index of 31; 5 papers cited 100+ times in the CRISPR and single-cell literature
Co-inventor on 3 USPTO patent applications covering sequencing methodology
Ad hoc reviewer for Nature Methods, PLOS Genetics, and Cell Systems
Invited speaker at ASHG and Cold Spring Harbor meetings
Filed via attorney as self-petitioner. No employer involvement required. I-140 approved without RFE; concurrent AOS filed immediately upon approval.
Principal Scientist
Kendall Square biotech (mRNA therapeutics)

mRNA delivery and lipid nanoparticle platforms

22 peer-reviewed publications; 7 issued US patents in lipid nanoparticle delivery
Salary in top 14% for principal scientists nationally per BLS and Radford data
Leading a 9-person delivery science team on a rare disease therapeutic program
Press coverage in STAT News and MIT Technology Review
Invited co-chair at AAPS Nanomedicine Workshop
Employer-sponsored EB-1B filed simultaneously by the company; self-petitioned EB-1A I-140 filed independently using the same evidence package. Two parallel green card paths active.
After EB-1A approval

What happens once the I-140 is approved.

For most nationalities, EB-1 priority dates are current — meaning you can file for permanent residence as soon as the I-140 is approved, with no waiting in a visa queue. If you are already in the United States in valid nonimmigrant status, the next step is adjustment of status (I-485), which lets you remain in the US while USCIS processes your permanent residence application. If you are abroad, consular processing through a US Embassy or Consulate is the route to your immigrant visa.

Because the EB-1A I-140 is self-petitioned, approval does not require you to remain with any employer. You can change jobs, institutions, or even fields between I-140 approval and the completion of the green card process — a flexibility that employer-sponsored categories like EB-1B cannot offer.

For Boston researchers who filed O-1A and EB-1A simultaneously, the typical outcome is approval of both simultaneously: O-1A remains valid for the duration of the EB-1A process, and once I-485 is filed, a concurrent work permit (EAD) is issued. Learn more about the O-1A to EB-1A pathway and the options available once your I-140 is in hand.

FAQ

Boston EB-1A questions.

Yes. EB-1A is entirely self-petitioned — no employer sponsor or job offer is required. You file the I-140 petition yourself (or through your attorney), and no employer needs to participate at any stage. This makes EB-1A the most portable green card path available and is why it is especially popular with Boston postdocs and researchers who are between positions, on short-term appointments, or whose institutions are unwilling to sponsor immigration.
EB-1A is self-petitioned and requires no employer; EB-1B requires a permanent job offer and an employer willing to file the I-140 on your behalf. Both skip PERM labor certification. The evidentiary standard for EB-1A — extraordinary ability — is slightly higher than EB-1B's outstanding researcher standard, but the self-petition flexibility of EB-1A means many Boston researchers pursue both simultaneously: the institution files EB-1B while the researcher self-petitions EB-1A using the same evidence package.
Yes, and for many Boston researchers this is the optimal strategy. The O-1A provides immediate nonimmigrant work authorization while the EB-1A I-140 is adjudicated. The two petitions use largely the same evidentiary record — publications, citations, expert letters, peer review history, and critical role documentation. Filing simultaneously avoids any gap in work authorization and starts the immigrant clock running immediately.
Yes. Because EB-1A is self-petitioned, your institution's willingness to sponsor has no bearing on your eligibility or your ability to file. Many Boston researchers whose departments lack immigration bandwidth, or who have split appointments across institutions, file EB-1A entirely independently. If your evidence meets the extraordinary ability standard, the petition can proceed without any employer involvement.
EB-1 (which includes EB-1A) priority dates are current for most nationalities in 2026, meaning there is generally no wait once the I-140 is approved. The exception is Indian nationals, who face a significant EB-1 backlog. For most Boston researchers, an approved EB-1A I-140 means you can file I-485 adjustment of status (if already in the US) or proceed to consular processing without waiting in a visa queue. Consult the monthly Visa Bulletin for the latest cutoff dates.